Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.

[1]  A. Sowunmi,et al.  Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated, Plasmodium falciparum malaria, in an area with high and increasing incidences of chloroquine resistance , 2005, Annals of tropical medicine and parasitology.

[2]  A. Hubbard,et al.  The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. , 2004, The American journal of tropical medicine and hygiene.

[3]  A. Sowunmi,et al.  Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment. , 2004, Parasite.

[4]  A. Sowunmi,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children , 2004, Parasitology.

[5]  A. Sowunmi,et al.  Open randomized study of pyrimethamine–sulphadoxine vs. pyrimethamine–sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children , 2004, Tropical medicine & international health : TM & IH.

[6]  S. Lamola,et al.  Relationship between age, molecular markers, and response to sulphadoxine–pyrimethamine treatment in Kampala, Uganda , 2004, Tropical medicine & international health : TM & IH.

[7]  S. Satpathy,et al.  Severe falciparum malaria , 2004, Indian journal of pediatrics.

[8]  U. d’Alessandro,et al.  History, Dynamics, and Public Health Importance of Malaria Parasite Resistance , 2004, Clinical Microbiology Reviews.

[9]  A. Sowunmi,et al.  Cotrimoxazole in the Treatment of Acute Uncomplicated Falciparum Malaria in Nigerian Children , 2004, Clinical drug investigation.

[10]  L. Gerena,et al.  Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. , 2004, The American journal of tropical medicine and hygiene.

[11]  P. Rosenthal,et al.  Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. , 2003, The Journal of infectious diseases.

[12]  A. Sowunmi,et al.  Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant, Plasmodium falciparum malaria , 2003, Annals of tropical medicine and parasitology.

[13]  P. Rosenthal,et al.  Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. , 2003, The American journal of tropical medicine and hygiene.

[14]  M. Kolczak,et al.  Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and Underdosing , 2003, Antimicrobial Agents and Chemotherapy.

[15]  L. Gerena,et al.  Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria , 2003, Annals of tropical medicine and parasitology.

[16]  W. Fawzi,et al.  Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  A. Sowunmi.  A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children , 2003, Annals of tropical medicine and parasitology.

[18]  M. Kolczak,et al.  Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. , 2003, The Journal of infectious diseases.

[19]  S. Meshnick,et al.  Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. , 2003, The American journal of tropical medicine and hygiene.

[20]  A. Muñoz,et al.  Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. , 2002, American journal of epidemiology.

[21]  J. E. Hyde,et al.  Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? , 2001, Trends in parasitology.

[22]  C. Drakeley,et al.  Risk factors for gametocyte carriage in Gambian children. , 2001, The American journal of tropical medicine and hygiene.

[23]  J. Trape.  The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.

[24]  G. Dorsey,et al.  Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. , 2000, The American journal of tropical medicine and hygiene.

[25]  R. Price,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[26]  N. White.  Why is it that antimalarial drug treatments do not always work , 1998 .

[27]  A. Sowunmi,et al.  Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[28]  J. E. Hyde,et al.  Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. , 1997, Molecular and biochemical parasitology.

[29]  A. Sowunmi,et al.  Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  K. Rieckmann,et al.  Risk factors of chloroquine resistance in Plasmodium falciparum malaria. , 1996, Acta tropica.

[31]  N. White,et al.  Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  A. Walker,et al.  Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. , 1993, The American journal of tropical medicine and hygiene.

[33]  D. Kyle,et al.  Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  A. Sowunmi,et al.  Malaria in Nigeria: a revisit. , 1990, Annals of tropical medicine and parasitology.

[35]  C. F. Hansford,et al.  The use of antimalarial drugs. , 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[36]  A. Shaper,et al.  Genetic neutropenia in people of African origin. , 1971, Lancet.

[37]  Ezeilo Gc.  Neutropenia in Africans. , 1971 .